- MoCRA facility registrations renew on a two-year clock, with the first full cycle landing in 2026.
- The FDA good manufacturing practice rule missed its end of 2025 deadline and is still pending.
- Under-one-million-dollar sellers get partial relief, with hard limits around eyes, injections and safety reports.
Makers and sellers of skin care in the United States are starting the first renewal period under the Modernization of Cosmetics Regulation Act, known as MoCRA, and the forms are surprising some smaller firms.
The statute calls for renewal every two years for a registered facility, plus a current product listing with ingredients from the responsible person, and that framework traces to December 2022. That signing marked the first broad rewrite of federal cosmetics law since 1938. Calendar math puts the initial repeat filings in 2026. FDA sends automatic email notices before each due date, so a stale inbox remains the easiest way to overlook a filing.
Shoppers may notice the impact indirectly. Online marketplaces and stores now more often request proof of registration and listing before they keep stocking a line, and plenty of indie labels rely on a contract manufacturer to maintain its separate facility filing. A label that believed its maker took care of all filings can learn otherwise only after a buyer asks for documents.
Narrower firms receive limited accommodation. Businesses averaging under one million dollars in yearly cosmetics sales over the prior three years are usually excused from facility registration and product listing. Products applied around the eyes, injected, intended for internal use, or made to alter appearance for longer than 24 hours fall outside that accommodation, and the obligation to report serious adverse events stays in place. A tiny line with a lip balm and a face oil can qualify, while a tiny line offering lash formulas cannot.
Manufacturing standards remain the bigger pending item. MoCRA directed the FDA to complete good manufacturing practice regulations for cosmetics by the close of 2025, yet the date passed with no final regulation, and firms monitoring the docket anticipate a proposal first followed by staged compliance, with added time for small operations. In the interval, the agency looks for reasonable controls at facilities even absent a detailed code.
Watch next for two markers: publication of the proposed manufacturing rule this year, and whether missed renewals prompt the first public enforcement steps under authorities that include mandatory recall and suspension of a facility registration. Labels that have not reviewed their own listings and their makers registrations should set time to audit them now.






